Literature DB >> 20924266

Young patients with branch retinal vein occlusion: a review of 60 cases.

Harhiu D Lam1, James M Lahey, John J Kearney, Ronald R Ng, Jeffrey M Lehmer, Stephen C Tanaka.   

Abstract

PURPOSE: To investigate the risk factors for branch retinal vein occlusion (BRVO) in young patients.
METHODS: Observational case series with retrospective comparative controls. The medical records of 60 consecutive patients (aged ≤ 49 years) with BRVO were reviewed to note patients' age, sex, body mass index, history of smoking, diabetes, hypertension, hyperlipidemia, and hormonal replacement therapy in women. Results were compared with those of a control group of 123 individuals.
RESULTS: An increased risk of BRVO was found in patients with a history of systemic hypertension, hyperlipidemia, and increased body mass index but not with diabetes, smoking, or hormone replacement therapy.
CONCLUSION: Systemic hypertension, hyperlipidemia, and increased body mass index are important risk factors for BRVO in young patients, just as in the older population. We recommend obtaining a complete blood count, reviewing the medical history, and evaluating the patient for systemic hypertension, obesity, and hyperlipidemia as part of the initial workup of young patients with BRVO. If no clear risk factors are found, a more extensive workup should be considered.

Entities:  

Mesh:

Year:  2010        PMID: 20924266     DOI: 10.1097/IAE.0b013e3181e79872

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  A Moyamoya Patient with Bilateral Consecutive Branch Retinal Vein Occlusion.

Authors:  Hande Güçlü; Vuslat Pelitli Gurlu; Sadık Altan Ozal; Haluk Esgin
Journal:  Neuroophthalmology       Date:  2016-02-29

2.  Branch retinal vein occlusion associated with quetiapine fumarate.

Authors:  Ku Chui Yong; Tan Aik Kah; Yeap Thye Ghee; Lim Chee Siang; Mae-Lynn Catherine Bastion
Journal:  BMC Ophthalmol       Date:  2011-08-25       Impact factor: 2.209

Review 3.  New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion.

Authors:  Jia Li; Yannis M Paulus; Yuanlu Shuai; Wangyi Fang; Qinghuai Liu; Songtao Yuan
Journal:  J Ophthalmol       Date:  2017-03-12       Impact factor: 1.909

4.  Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age.

Authors:  Maurizio Battaglia Parodi; Francesco Romano; Alessandro Arrigo; Stefano Mercuri; Alessandro Franceschi; Francesco Bandello
Journal:  Biomed Res Int       Date:  2020-06-17       Impact factor: 3.411

5.  Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus.

Authors:  Harsha Bhattacharjee; Manabjyoti Barman; Divakant Misra; Prabhjot K Multani; Shriya Dhar; Umesh C Behera; Taraprasad Das; Clare Gilbert; G V S Murthy; R Rajalakshmi; Hira B Pant
Journal:  Indian J Ophthalmol       Date:  2020-02       Impact factor: 1.848

Review 6.  Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data.

Authors:  Petr Kolar
Journal:  J Ophthalmol       Date:  2014-06-09       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.